Income Statement

TWIST BIOSCIENCE CORP

TWST
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Sep 30, 2025 2025 FY Sep 30, 2024 2024 FY Sep 30, 2023 2023 FY Sep 30, 2022 2022 FY Sep 30, 2021 2021 FY Sep 30, 2020 2020 FY Sep 30, 2019 2019 FY
Revenue
- - - - - - -
Cost of Revenue
185.57 179.63 155.38 119.33 80.62 61.41 47.43
Gross Profit
-185.57 -179.63 -155.38 -119.33 -80.62 -61.41 -47.43
Operating Expenses
327.26 309.25 296.63 333.26 204.97 146.27 115.81
Research & Development
80.29 90.85 106.89 120.31 69.07 43.01 35.68
Selling, General & Administrative
246.98 218.40 189.74 212.95 135.90 103.27 80.13
Other Operating Expenses
- - - - - - -
Operating Income
-512.83 -488.88 -452.01 -452.59 -285.59 -207.68 -163.24
Non-Operating Income
-435.88 -280.71 -248.55 -224.31 -131.57 -68.13 -55.86
Interest Income
11.36 15.34 14.37 3.06 0.44 1.50 3.03
Interest Expense
- - 0.01 0.08 0.37 0.79 1.29
Other Non-Op Income / Expense
-0.90 -2.65 -0.67 -1.09 -1.37 -0.18 -0.27
Income Before Tax
-76.95 -208.17 -203.47 -228.27 -154.03 -139.55 -107.38
Income Tax Expense
0.72 0.56 1.15 -10.41 -1.93 0.38 0.29
Non-Controlling Interest
- - - - - - -
Net Income
-77.67 -208.73 -204.62 -217.86 -152.10 -139.93 -107.67
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Sep 30, 2025 2025 FY Sep 30, 2024 2024 FY Sep 30, 2023 2023 FY Sep 30, 2022 2022 FY Sep 30, 2021 2021 FY Sep 30, 2020 2020 FY Sep 30, 2019 2019 FY
Depreciation & Amortization
- - - - - - -
EBITDA
-487.98 -457.44 -422.70 -436.07 -275.79 -201.00 -157.12
Earnings Per Share (Basic)
-1.30 -3.60 -3.60 -4.04 - - -
Diluted EPS
-1.30 -3.60 -3.60 -4.04 - - -
Weighted Average Shares
59.81 58.02 56.89 53.89 - - -
Diluted Weighted Avg Shares
59.81 58.02 56.89 53.89 - - -
Comprehensive Income
-77.78 -208.49 -203.53 -220.25 -151.64 -140.03 -107.58